Stocktoria
Incannex Healthcare Inc. IXHL
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2022-03-18
Incannex Healthcare Inc. statistics & valuation
Market cap$40.9M
P / B3.1×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2023 |
|---|---|---|---|---|
| Operating margin | -27661.6% | -250341.7% | — | — |
| Net margin | -54517.4% | -153825.0% | — | — |
| FCF margin | -14559.3% | -134350.0% | — | — |
| Return on assets | -229.3% | -108.3% | — | -205.2% |
| Return on equity | -350.2% | -164.6% | — | -234.4% |
| Current ratio | 2.86 | 2.88 | 6.70 | 9.02 |
| Revenue growth | 616.7% | — | — | — |
Source: SEC EDGAR filings · CIK 0001873875 · as of 2025-06-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.